Industry News

Tracks company news, strategic changes, funding activities, and personnel adjustments across the blockchain and crypto industries, delivering a full-spectrum industry overview for our users.

Just 6 Days After Launching ChatGPT Health, OpenAI Is Surpassed on Its Own Medical Benchmark

In a significant development in the AI healthcare sector, Baichuan Intelligence has surpassed OpenAI's GPT-5.2 High on the HealthBench benchmark—a medical evaluation dataset created by OpenAI with input from 260+ doctors across 60 countries—just six days after OpenAI launched ChatGPT Health. Baichuan's new model, Baichuan-M3, achieved a top score of 65.1 and also led in the more challenging HealthBench Hard subset, while demonstrating the lowest hallucination rate (3.5%) without relying on external tools. Key to M3’s performance is its Fact Aware RL technique, which improves diagnostic accuracy by balancing factual precision with proactive questioning. The model avoids both over-confident errors and overly vague responses. Additionally, Baichuan introduced SCAN-bench, a new evaluation framework designed to simulate real doctor-patient interactions. In tests, M3 outperformed human specialists in areas like safety stratification, clarity, and diagnostic questioning, partly due to its ability to integrate knowledge across medical disciplines. Baichuan is now rolling out the model via its consumer product Baixiaoying (百小应), offering tailored interfaces for both doctors and patients. The company emphasizes a focus on "serious medicine," prioritizing complex areas like oncology over general wellness, aiming to augment—not just assist—medical professionals. According to CEO Wang Xiaochuan, enhancing AI’s capability in high-stakes medical scenarios is crucial for building user trust and advancing toward AGI through deeper biological understanding.

marsbit01/14 02:31

Just 6 Days After Launching ChatGPT Health, OpenAI Is Surpassed on Its Own Medical Benchmark

marsbit01/14 02:31

RWA Weekly Report|Private Credit Surges Nearly 40%; Bipartisan Senate Inclined to Adjust GENIUS Stablecoin Yield Rules (1.7-1.13)

RWA Weekly Report: Private Credit Surges Nearly 40%; Bipartisan Senate Support to Adjust GENIUS Act Stablecoin Yield Rules (Jan 7–13) The on-chain value of Real World Assets (RWA) grew to $20.81 billion, a 6.23% weekly increase, though broader RWA valuations dropped sharply due to statistical adjustments. Private credit saw a 39% surge, reaching $3.2 billion, while U.S. Treasuries and commodities remained core holdings. Stablecoin user addresses increased, though total market cap slightly declined. Key developments include a new U.S. crypto market draft that prohibits interest payments for merely holding stablecoins, though rewards for trading and staking remain allowed. The bipartisan Senate is considering amendments to the GENIUS Act, potentially limiting which institutions can offer yields. South Korea lifted a nine-year ban on corporate crypto investments, allowing firms to allocate up to 5% of net assets to cryptocurrencies. Notable funding rounds included Rain’s $250 million raise and VelaFi’s $20 million Series B. Cathie Wood suggested the U.S. might directly purchase Bitcoin for national reserves. Meanwhile, Coinbase may withdraw support for the CLARITY Act if it restricts stablecoin rewards. Projects like Ondo Finance and MSX (MyStonks) are advancing tokenized assets, with MSX reducing RWA trading fees to enhance user adoption.

marsbit01/13 15:11

RWA Weekly Report|Private Credit Surges Nearly 40%; Bipartisan Senate Inclined to Adjust GENIUS Stablecoin Yield Rules (1.7-1.13)

marsbit01/13 15:11

活动图片